Indiana University's Launch Accelerator for Biosciences

What Indiana University's Launch Accelerator for Biosciences does

Indiana University's Launch Accelerator for Biosciences (IU LAB) is a flagship life science innovation initiative established in 2024 as a subsidiary of IU Inc., a newly formed nonprofit organization created by Indiana University to strengthen industry and government partnerships. Operating from Bloomington, Indiana, IU LAB is one of three core subsidiaries under IU Inc., alongside the IU Applied Research Center (ARC) and IU Realty. The accelerator is led by David Rosenberg as President and CEO and serves early-stage bioscience startups and entrepreneurs seeking to commercialize life science research originating from or affiliated with the university.

The core offering is a managed-services accelerator program providing bioscience founders with access to Indiana University's research infrastructure, faculty expertise, industry partnerships, mentorship, and commercialization pathways. IU LAB's primary customer segment is early-stage bioscience companies and entrepreneurs working on technology translation in life sciences, with horizontal segmentation centered on the use case of research commercialization. The program does not sell software or technology products; instead, it provides coordinated services and ecosystem access that leverages IU's institutional assets, including the nation's largest medical school (IU School of Medicine), two R1 research campuses, and $1 billion+ in annual research expenditures.

IU LAB operates within a managed-services revenue model as a nonprofit entity, with pricing details not publicly disclosed. Its go-to-market motion is community-led: it leverages IU's nine campuses, 90,000+ student population, research and innovation events, IU News and Media, and the university's broader marketing infrastructure to attract startup founders and industry partners. No specific funding rounds, external ownership, or revenue figures have been disclosed for the entity; its economic footprint is best understood in the context of IU's $250 million commitment to life and bioscience research and Indiana's $99 billion life sciences economy.

Name

Indiana University's Launch Accelerator for Biosciences

Legal name

The Trustees of Indiana University

Website

https://iu.edu

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Indiana University's Launch Accelerator for Biosciences (IU LAB) is a 2024-founded nonprofit accelerator that supports early-stage bioscience startups and entrepreneurs by providing access to university research infrastructure, faculty expertise, industry partnerships, and commercialization pathways under IU Inc.

Ownership category

akta.pro rank

Product category

Life Sciences Accelerator Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Public Research Universities with National Laboratories/Big Science Facilities (EDAHAAAJ), Makerspace, Innovation Lab & Fab Lab Operations (Tools, Safety, Programming) (EDAEAGAI)

Keywords

• Life sciences accelerator
• Bioscience startup incubation
• University research commercialization
• Biotech innovation hub
• Biopharma venture support

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Life Science Innovation Services: IU LAB operates as a nonprofit accelerator under IU Inc., providing bioscience innovation support services including mentorship, resources, and ecosystem access for startups and researchers commercializing life science technologies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

IU LAB is Indiana University's life science innovation initiative operating as a subsidiary of IU Inc. It provides bioscience startups and entrepreneurs with access to university research infrastructure, faculty expertise, mentorship, industry partnerships, and commercialization resources to translate life science research from university laboratories into commercially viable products and companies.

Product overview

IU LAB (Launch Accelerator for Biosciences) is a dedicated life science innovation initiative under IU Inc. that supports the acceleration and commercialization of bioscience research and startups at Indiana University.

Differentiator

Problem solved

Functional benefit

Products and services

• IU Launch Accelerator for Biosciences (IU LAB) A bioscience accelerator program that supports early-stage life science startups and entrepreneurs at Indiana University with mentorship, access to research facilities, faculty expertise, industry partnerships, regulatory guidance, and commercialization support.

Quantifiable outcome

• $99 billion value of Indiana's life sciences economy

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• IndieBio: Leading independent biotech accelerator offering equity-funded programming to early-stage life science startups; serves as a benchmark competitor for university-affiliated programs like IU LAB.
• Johns Hopkins Technology Ventures: Johns Hopkins' tech transfer and venture arm covering a broader portfolio of research areas including biosciences; a larger and more established university innovation platform relative to IU LAB.

Direct peers

• MATTER: Chicago-based healthcare and life sciences incubator working with startups, hospitals, and universities; comparable in mission of accelerating bioscience commercialization in the Midwest.
• Stanford BioDesign: Stanford's flagship biomedical innovation program that trains interdisciplinary teams to translate research into medical technologies; mirrors IU LAB's faculty-and-resource-driven commercialization model.
• BioGenerator: St. Louis-based bioscience startup generator with a similar accelerator/incubator model for university-derived life science ventures, comparable in scope to IU LAB.
• UCSF Innovation Ventures: UCSF's tech transfer and bioscience startup accelerator, focused on commercializing life science research from a top U.S. medical school — directly comparable to IU LAB's role at Indiana University.
• QB3 (UC Berkeley): UC Berkeley's bioscience incubator that supports startups from university research; a direct functional peer in university-affiliated life science venture formation.
• MIT linQ Catalyst: MIT's biomedical accelerator supporting translational projects from MIT labs into startups, closely paralleling IU LAB's role of moving university bioscience IP toward commercialization.
• Emory Biomedical Catalyst: Emory's bioscience and biomedical innovation programs supporting faculty-led ventures, sharing IU LAB's emphasis on translating academic medical research into companies.
• University of Michigan Fast Forward Medical Innovation: University of Michigan's biomedical innovation hub funding and mentoring physician-led ventures; directly comparable as a Big Ten research-university bioscience accelerator.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xtwitter.com/IndianaUniv
• YouTubeyoutube.com/user/iu
• Facebookfacebook.com/IndianaUniversity
• LinkedInlinkedin.com/company/indiana-university
• Instagraminstagram.com/iubloomington

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indiana University's Launch Accelerator for Biosciences